Skip to Content

Chlorothiazide Sodium Injection

Last Updated: April 9, 2018
Status: Current

Chlorothiazide Sodium Injection

Products Affected - Description
    • Chlorothiazide injection, American Regent, 500 mg, vial, 1 count, NDC 00517-1820-01
    • Chlorothiazide injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0658-20
    • Chlorothiazide injection, Mylan Institutional, 500 mg, vial, 1 count, NDC 67457-0263-30
    • Chlorothiazide injection, Sagent, 500 mg, vial, 1 count, NDC 25021-0305-20
Reason for the Shortage
    • Akorn has chlorothiazide injection on shortage due to manufacturing delays.
    • Sagent has chlorothiazide injection on shortage due to increased demand.
    • Sun Pharma refuses to provide availability information on any of their products.
Available Products
    • Sodium Diuril injection, Akorn, 500 mg, vial, 1 count, NDC 76478-0711-40
    • Chlorothiazide injection, Akorn, 500 mg, vial, 1 count, NDC 17478-0419-40

Estimated Resupply Dates

    • American Regent has chlorothiazide 500 mg vials on back order and the company cannot estimate a release date.
    • Fresenius Kabi has chlorothiazide 500 mg vials on back order and the company estimates a release date of mid-April 2018.
    • Mylan Institutional has chlorothiazide 500 mg vials on back order and the company estimates a release date of early- to mid-April 2018.
    • Sagent has chlorothiazide 500 mg vials on allocation.

Updated

Updated April 9, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 11, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide